Prof. Dr. EVREN ÖZDEMİR

Yayın Ağı

Makaleler 30

1. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

2. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+cell numbers

Aerts-Kaya F. S. F., Koca G., Sharafi P., Sayla F. C., Uckan-Cetinkaya D., Ozdemir E.

BONE MARROW TRANSPLANTATION , cilt.53, sa.9, ss.1225-1227, 2018 (SCI-Expanded, Scopus)

3. Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin lymphoma (HL): Impact of cycle 2 PET result on modified progression-free survival (mPFS).

Chen R. W., Ansell S. M., Gallamini A., Connors J. M., Savage K. J., Collins G. P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)

4. Successful treatment of relapsed/refractory Hodgkins lymphoma with nivolumab in a heavily pretreated patient with progressive disease after both autologous and allogeneic stem cell transplantation

Aslan A., Aras T., ÖZDEMİR E.

LEUKEMIA & LYMPHOMA , cilt.58, sa.3, ss.754-755, 2017 (SCI-Expanded, Scopus)

5. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience

Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.16, sa.5, ss.269-274, 2016 (SCI-Expanded, Scopus)

6. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75

Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin)

7. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)

8. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study

Bayraktar-Ekincioglu A., Demirkan K., KESKIN B., ASLANTAS O., Ozdemir E.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE , cilt.21, sa.4, ss.216-221, 2014 (SCI-Expanded, Scopus)

9. Ibrutinib: From Molecule to Medicine

Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded, Scopus, TRDizin)

10. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)

11. Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review

Ozdemir E., Kansu E.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.2, ss.188-190, 2013 (SCI-Expanded, Scopus, TRDizin)

12. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment

CAMURDANOGLU B. Z., ESENDAĞLI G., Ozdemir E., CANPINAR H., Guc D., Kansu E.

CYTOKINE , cilt.61, sa.2, ss.572-577, 2013 (SCI-Expanded, Scopus)

13. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.

ACTA HAEMATOLOGICA , cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)

14. Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient

UZ B., Ozdemir E., Aksu S., AKYOL T. K., JONES R.

TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.2, ss.199-200, 2012 (SCI-Expanded, Scopus, TRDizin)

15. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer

ÖZMEN F., OZMEN M. M., Ozdemir E., MORAN M., SECKIN S., Guc D., et al.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.17, sa.27, ss.3220-3228, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Acute promyelocytic leukemia in a young patient with breast cancer

KARA O., Ozdemir E., Arslan C., DOGAN E., ALTUNDAG K.

MEDICAL ONCOLOGY , cilt.28, sa.1, ss.249-250, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma

ARARAT E., SAHIN I., Ozdemir E., ALTUNDAG K.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.151, sa.5, ss.530-531, 2010 (SCI-Expanded, Scopus)

18. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)

19. Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy

FIRAT F., OZEN G., YILDIZ G., SAGLAM A., ONDER S., TAN E., et al.

LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)

20. Breast Cancer in a Patient with Agnogenic Myeloid Metaplasia

ARIK Z., OZKAN C., Ozdemir E., ALTUNDAG K.

SOUTHERN MEDICAL JOURNAL , cilt.103, sa.10, ss.1075-1076, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Oyan B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.

CLINICAL TRANSPLANTATION , cilt.23, sa.6, ss.839-847, 2009 (SCI-Expanded, Scopus)

22. Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation

Ozdemir E., BAYRAKTAR M., SÖKMENSÜER C., Kir K. M., Kansu E.

CLINICAL TRANSPLANTATION , cilt.23, sa.6, ss.981-984, 2009 (SCI-Expanded, Scopus)

23. The Lollipop with Strawberry Aroma May Be Promising in Reduction of Infusion-Related Nausea and Vomiting during the Infusion of Cryopreserved Peripheral Blood Stem Cells

Ozdemir E., AKGEDIK K., AKDOGAN S., Kansu E.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.14, sa.12, ss.1425-1428, 2008 (SCI-Expanded, Scopus)

24. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.

LEUKEMIA & LYMPHOMA , cilt.47, sa.8, ss.1545-1552, 2006 (SCI-Expanded, Scopus)

25. Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis

Ozdemir E., KOC Y., KANSU E.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.6, ss.474, 2006 (SCI-Expanded, Scopus)

26. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia

Ozdemir E., MOLLDREM J.

BONE MARROW TRANSPLANTATION , cilt.37, sa.8, ss.785-786, 2006 (SCI-Expanded, Scopus)

27. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation

OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.11, sa.9, ss.688-697, 2005 (SCI-Expanded, Scopus)

28. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8(+) T cells

Ozdemir E., ST JOHN L., GILLESPIE G., ROWLAND-JONES S., CHAMPLIN R., MOLLDREM J., et al.

BLOOD , cilt.100, sa.10, ss.3690-3697, 2002 (SCI-Expanded, Scopus)

29. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia

CAGIRGAN S., SENCAN M., TOMBULOGLU M., Ozdemir E., HEKIMGIL M., BUYUKKECECI F.

LEUKEMIA & LYMPHOMA , cilt.29, ss.423-425, 1998 (SCI-Expanded, Scopus)

30. Focal myositis

KOCANAOGULLARI H., Ozdemir E., KESER G., TUNCBAY T., GUMUSDIS G., DOGANAVSARGIL E.

CLINICAL RHEUMATOLOGY , cilt.17, sa.1, ss.65-67, 1998 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.

57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

2. Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation

ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.

57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

3. The retrospective analysis of central nervous system lymphomas: Single-center experience.

Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

4. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

5. HODGKIN'S LYMPHOMA: DIAGNOSIS AND STAGING

ÖZDEMİR E.

5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

6. High-dose chemotherapy and autologous stem cell transplantation in refractory/metastatic nonseminomatous germ cell-tumors: A retrospective study of the Turkish Oncology Association.

Ozturk M., Arpaci F., Ozaydin S., Karadurmus N., Ozdemir E., Ataergin S., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

7. Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone

ÖZDEMİR E., Koc Y., Kars A., Turker A., Tekuzman G., KANSU E.

49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

294

H-İndeks (WoS)

Atıf (Scopus)

282

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler